{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:40:57Z","timestamp":1790430057788,"version":"4.1.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003180","name":"Academic Medical Center","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003180","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s11154-018-9460-5","type":"journal-article","created":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T02:06:35Z","timestamp":1536717995000},"page":"81-92","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Bone health in patients with inborn errors of metabolism"],"prefix":"10.1007","volume":"19","author":[{"given":"M.","family":"Langeveld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. E. M.","family":"Hollak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,12]]},"reference":[{"issue":"6","key":"9460_CR1","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1097\/MED.0000000000000366","volume":"24","author":"PM Dussault","year":"2017","unstructured":"Dussault PM, Lazzari AA. Epilepsy and osteoporosis risk. Curr Opin Endocrinol Diabetes Obes. 2017;24(6):395\u2013401. \n                    https:\/\/doi.org\/10.1097\/MED.0000000000000366\n                    \n                  .","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"2","key":"9460_CR2","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/MOP.0000000000000064","volume":"26","author":"J Gattineni","year":"2014","unstructured":"Gattineni J. Inherited disorders of calcium and phosphate metabolism. Curr Opin Pediatr. 2014;26(2):215\u201322. \n                    https:\/\/doi.org\/10.1097\/MOP.0000000000000064\n                    \n                  .","journal-title":"Curr Opin Pediatr"},{"issue":"3","key":"9460_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s11914-016-0309-0","volume":"14","author":"A Linglart","year":"2016","unstructured":"Linglart A, Biosse-Duplan M. Hypophosphatasia. Curr Osteoporos Rep. 2016;14(3):95\u2013105. \n                    https:\/\/doi.org\/10.1007\/s11914-016-0309-0\n                    \n                  .","journal-title":"Curr Osteoporos Rep"},{"issue":"5S2","key":"9460_CR4","doi-asserted-by":"publisher","first-page":"5S85","DOI":"10.1016\/S0929-693X(18)30021-6","volume":"24","author":"C Fonta","year":"2017","unstructured":"Fonta C, Salles JP. Neuromuscular features of hypophosphatasia. Arch Pediatr. 2017;24(5S2):5S85\u20135S8. \n                    https:\/\/doi.org\/10.1016\/S0929-693X(18)30021-6\n                    \n                  .","journal-title":"Arch Pediatr"},{"issue":"2","key":"9460_CR5","doi-asserted-by":"publisher","first-page":"230","DOI":"10.11138\/ccmbm\/2017.14.1.230","volume":"14","author":"F Conti","year":"2017","unstructured":"Conti F, Ciullini L, Pugliese G. Hypophosphatasia: clinical manifestation and burden of disease in adult patients. Clin Cases Miner Bone Metab. 2017;14(2):230\u20134. \n                    https:\/\/doi.org\/10.11138\/ccmbm\/2017.14.1.230\n                    \n                  .","journal-title":"Clin Cases Miner Bone Metab"},{"issue":"4","key":"9460_CR6","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1210\/jc.2006-1902","volume":"92","author":"MP Whyte","year":"2007","unstructured":"Whyte MP, Mumm S, Deal C. Adult hypophosphatasia treated with teriparatide. J Clin Endocrinol Metab. 2007;92(4):1203\u20138. \n                    https:\/\/doi.org\/10.1210\/jc.2006-1902\n                    \n                  .","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"9460_CR7","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1056\/NEJMoa1106173","volume":"366","author":"MP Whyte","year":"2012","unstructured":"Whyte MP, Greenberg CR, Salman NJ, Bober MB, McAlister WH, Wenkert D, et al. Enzyme-replacement therapy in life-threatening hypophosphatasia. N Engl J Med. 2012;366(10):904\u201313. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1106173\n                    \n                  .","journal-title":"N Engl J Med"},{"issue":"9","key":"9460_CR8","doi-asserted-by":"publisher","first-page":"e85971","DOI":"10.1172\/jci.insight.85971","volume":"1","author":"MP Whyte","year":"2016","unstructured":"Whyte MP, Madson KL, Phillips D, Reeves AL, McAlister WH, Yakimoski A, et al. Asfotase alfa therapy for children with hypophosphatasia. JCI Insight. 2016;1(9):e85971. \n                    https:\/\/doi.org\/10.1172\/jci.insight.85971\n                    \n                  .","journal-title":"JCI Insight"},{"issue":"1","key":"9460_CR9","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1210\/jc.2015-3462","volume":"101","author":"Michael P. Whyte","year":"2016","unstructured":"Whyte MP, Rockman-Greenberg C, Ozono K, Riese R, Moseley S, Melian A, et al. Asfotase alfa treatment improves survival for perinatal and infantile Hypophosphatasia. J Clin Endocrinol Metab. 2016;101(1):334\u201342. \n                    https:\/\/doi.org\/10.1210\/jc.2015-3462\n                    \n                  .","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"9460_CR10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ymgmr.2017.10.006","volume":"14","author":"Gregory Costain","year":"2018","unstructured":"Costain G, Moore AM, Munroe L, Williams A, Zlotnik Shaul R, Rockman-Greenberg C, et al. Enzyme replacement therapy in perinatal hypophosphatasia: case report of a negative outcome and lessons for clinical practice. Mol Genet Metab Rep. 2018;14:22\u20136. \n                    https:\/\/doi.org\/10.1016\/j.ymgmr.2017.10.006\n                    \n                  .","journal-title":"Molecular Genetics and Metabolism Reports"},{"key":"9460_CR11","unstructured":"Ruppe MD. X-Linked Hypophosphatemia. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K et al., editors. GeneReviews((R)). Seattle (WA) 1993. Available from \n                    http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK83985\/\n                    \n                   PubMedPMID:22319799. Accessed 1 June 2018."},{"issue":"4","key":"9460_CR12","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00467-011-2046-z","volume":"27","author":"C Quinlan","year":"2012","unstructured":"Quinlan C, Guegan K, Offiah A, Neill RO, Hiorns MP, Ellard S, et al. Growth in PHEX-associated X-linked hypophosphatemic rickets: the importance of early treatment. Pediatr Nephrol. 2012;27(4):581\u20138. \n                    https:\/\/doi.org\/10.1007\/s00467-011-2046-z\n                    \n                  .","journal-title":"Pediatr Nephrol"},{"issue":"7","key":"9460_CR13","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1002\/jbmr.340","volume":"26","author":"Thomas O Carpenter","year":"2011","unstructured":"Carpenter TO, Imel EA, Holm IA, de Beur JSM, Insogna KL. A clinician\u2019s guide to X-linked hypophosphatemia. J Bone Miner Res. 2011;26(7):1381\u20138. \n                    https:\/\/doi.org\/10.1002\/jbmr.340\n                    \n                  .","journal-title":"Journal of Bone and Mineral Research"},{"key":"9460_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ghir.2017.08.001","volume":"36","author":"Anya Rothenbuhler","year":"2017","unstructured":"Rothenbuhler A, Esterle L, Gueorguieva I, Salles JP, Mignot B, Colle M, et al. Two-year recombinant human growth hormone (rhGH) treatment is more effective in pre-pubertal compared to pubertal short children with X-linked hypophosphatemic rickets (XLHR). Growth Hormon IGF Res. 2017;36:11\u20135. \n                    https:\/\/doi.org\/10.1016\/j.ghir.2017.08.001\n                    \n                  .","journal-title":"Growth Hormone & IGF Research"},{"issue":"4","key":"9460_CR15","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1172\/JCI72829","volume":"124","author":"EA Imel","year":"2014","unstructured":"Carpenter TO, Imel EA, Ruppe MD, Weber TJ, Klausner MA, Wooddell MM, et al. Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia. J Clin Invest. 2014;124(4):1587\u201397. \n                    https:\/\/doi.org\/10.1172\/JCI72829\n                    \n                  .","journal-title":"J Clin Invest"},{"key":"9460_CR16","unstructured":"Strensiq EPAR: \n                    http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Public_assessment_report\/human\/003794\/WC500194340.pdf\n                    \n                  ."},{"issue":"23\u201324","key":"9460_CR17","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s10354-010-0841-y","volume":"160","author":"P Mikosch","year":"2010","unstructured":"Mikosch P, Hughes D. An overview on bone manifestations in Gaucher disease. Wien Med Wochenschr. 2010;160(23\u201324):609\u201324. \n                    https:\/\/doi.org\/10.1007\/s10354-010-0841-y\n                    \n                  .","journal-title":"Wien Med Wochenschr"},{"issue":"Suppl 1","key":"9460_CR18","first-page":"674","volume":"13","author":"EH Schuchman","year":"2016","unstructured":"Schuchman EH, Wasserstein MP. Types a and B Niemann-pick disease. Pediatr Endocrinol Rev. 2016;13(Suppl 1):674\u201381.","journal-title":"Pediatr Endocrinol Rev"},{"issue":"1","key":"9460_CR19","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10545-012-9503-0","volume":"36","author":"M Wasserstein","year":"2013","unstructured":"Wasserstein M, Godbold J, McGovern MM. Skeletal manifestations in pediatric and adult patients with Niemann pick disease type B. J Inherit Metab Dis. 2013;36(1):123\u20137. \n                    https:\/\/doi.org\/10.1007\/s10545-012-9503-0\n                    \n                  .","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"9460_CR20","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1067\/mpd.2003.113","volume":"142","author":"MP Wasserstein","year":"2003","unstructured":"Wasserstein MP, Larkin AE, Glass RB, Schuchman EH, Desnick RJ, McGovern MM. Growth restriction in children with type B Niemann-pick disease. J Pediatr. 2003;142(4):424\u20138. \n                    https:\/\/doi.org\/10.1067\/mpd.2003.113\n                    \n                  .","journal-title":"J Pediatr"},{"issue":"Suppl 5","key":"9460_CR21","doi-asserted-by":"publisher","first-page":"v4","DOI":"10.1093\/rheumatology\/ker394","volume":"50","author":"J Muenzer","year":"2011","unstructured":"Muenzer J. Overview of the mucopolysaccharidoses. Rheumatology (Oxford). 2011;50(Suppl 5):v4\u201312. \n                    https:\/\/doi.org\/10.1093\/rheumatology\/ker394\n                    \n                  .","journal-title":"Rheumatology (Oxford)"},{"key":"9460_CR22","doi-asserted-by":"publisher","DOI":"10.1017\/S1462399408000550","volume":"10","author":"LA Clarke","year":"2008","unstructured":"Clarke LA. The mucopolysaccharidoses: a success of molecular medicine. Expert Rev Mol Med. 2008;10:e1. \n                    https:\/\/doi.org\/10.1017\/S1462399408000550\n                    \n                  .","journal-title":"Expert Rev Mol Med"},{"issue":"4","key":"9460_CR23","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s13244-013-0246-8","volume":"4","author":"S Palmucci","year":"2013","unstructured":"Palmucci S, Attina G, Lanza ML, Belfiore G, Cappello G, Foti PV, et al. Imaging findings of mucopolysaccharidoses: a pictorial review. Insights Imaging. 2013;4(4):443\u201359. \n                    https:\/\/doi.org\/10.1007\/s13244-013-0246-8\n                    \n                  .","journal-title":"Insights Imaging"},{"issue":"12","key":"9460_CR24","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1002\/pd.1970121207","volume":"12","author":"M Beck","year":"1992","unstructured":"Beck M, Braun S, Coerdt W, Merz E, Young E, Sewell AC. Fetal presentation of Morquio disease type a. Prenat Diagn. 1992;12(12):1019\u201329.","journal-title":"Prenat Diagn"},{"issue":"1","key":"9460_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3233\/PRM-2012-0194","volume":"5","author":"NR Guarany","year":"2012","unstructured":"Guarany NR, Schwartz IV, Guarany FC, Giugliani R. Functional capacity evaluation of patients with mucopolysaccharidosis. J Pediatr Rehabil Med. 2012;5(1):37\u201346. \n                    https:\/\/doi.org\/10.3233\/PRM-2012-0194\n                    \n                  .","journal-title":"J Pediatr Rehabil Med"},{"issue":"2","key":"9460_CR26","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s10545-010-9059-9","volume":"33","author":"A Tylki-Szymanska","year":"2010","unstructured":"Tylki-Szymanska A, Marucha J, Jurecka A, Syczewska M, Czartoryska B. Efficacy of recombinant human alpha-L-iduronidase (laronidase) on restricted range of motion of upper extremities in mucopolysaccharidosis type I patients. J Inherit Metab Dis. 2010;33(2):151\u20137. \n                    https:\/\/doi.org\/10.1007\/s10545-010-9059-9\n                    \n                  .","journal-title":"J Inherit Metab Dis"},{"issue":"Suppl 1","key":"9460_CR27","first-page":"141","volume":"12","author":"S Tomatsu","year":"2014","unstructured":"Tomatsu S, Yasuda E, Patel P, Ruhnke K, Shimada T, Mackenzie WG, et al. Morquio a syndrome: diagnosis and current and future therapies. Pediatr Endocrinol Rev. 2014;12(Suppl 1):141\u201351.","journal-title":"Pediatr Endocrinol Rev"},{"issue":"3","key":"9460_CR28","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ymgme.2017.05.008","volume":"121","author":"E Oussoren","year":"2017","unstructured":"Oussoren E, Bessems J, Pollet V, van der Meijden JC, van der Giessen LJ, Plug I, et al. A long term follow-up study of the development of hip disease in Mucopolysaccharidosis type VI. Mol Genet Metab. 2017;121(3):241\u201351. \n                    https:\/\/doi.org\/10.1016\/j.ymgme.2017.05.008\n                    \n                  .","journal-title":"Mol Genet Metab"},{"issue":"5","key":"9460_CR29","doi-asserted-by":"publisher","first-page":"386","DOI":"10.2106\/JBJS.O.00601","volume":"98","author":"Eveline J. Langereis","year":"2016","unstructured":"Langereis EJ, den Os MM, Breen C, Jones SA, Knaven OC, Mercer J, et al. Progression of hip dysplasia in Mucopolysaccharidosis type I hurler after successful hematopoietic stem cell transplantation. J Bone Joint Surg Am. 2016;98(5):386\u201395. \n                    https:\/\/doi.org\/10.2106\/JBJS.O.00601\n                    \n                  .","journal-title":"The Journal of Bone and Joint Surgery"},{"issue":"2","key":"9460_CR30","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s10545-014-9737-0","volume":"38","author":"MM Brands","year":"2015","unstructured":"Brands MM, Gungor D, van den Hout JM, Karstens FP, Oussoren E, Plug I, et al. Pain: a prevalent feature in patients with mucopolysaccharidosis. Results of a cross-sectional national survey. J Inherit Metab Dis. 2015;38(2):323\u201331. \n                    https:\/\/doi.org\/10.1007\/s10545-014-9737-0\n                    \n                  .","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"9460_CR31","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.beem.2014.08.010","volume":"29","author":"LA Clarke","year":"2015","unstructured":"Clarke LA, Hollak CE. The clinical spectrum and pathophysiology of skeletal complications in lysosomal storage disorders. Best Pract Res Clin Endocrinol Metab. 2015;29(2):219\u201335. \n                    https:\/\/doi.org\/10.1016\/j.beem.2014.08.010\n                    \n                  .","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"11","key":"9460_CR32","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.bbadis.2011.07.013","volume":"1812","author":"E Oussoren","year":"2011","unstructured":"Oussoren E, Brands MM, Ruijter GJ, der Ploeg AT, Reuser AJ. Bone, joint and tooth development in mucopolysaccharidoses: relevance to therapeutic options. Biochim Biophys Acta. 2011;1812(11):1542\u201356. \n                    https:\/\/doi.org\/10.1016\/j.bbadis.2011.07.013\n                    \n                  .","journal-title":"Biochim Biophys Acta"},{"issue":"12","key":"9460_CR33","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1016\/j.joca.2013.08.001","volume":"21","author":"V Opoka-Winiarska","year":"2013","unstructured":"Opoka-Winiarska V, Jurecka A, Emeryk A, Tylki-Szymanska A. Osteoimmunology in mucopolysaccharidoses type I, II, VI and VII. Immunological regulation of the osteoarticular system in the course of metabolic inflammation. Osteoarthr Cartil. 2013;21(12):1813\u201323. \n                    https:\/\/doi.org\/10.1016\/j.joca.2013.08.001\n                    \n                  .","journal-title":"Osteoarthr Cartil"},{"issue":"2","key":"9460_CR34","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ymgme.2014.12.001","volume":"114","author":"S Tomatsu","year":"2015","unstructured":"Tomatsu S, Almeciga-Diaz CJ, Montano AM, Yabe H, Tanaka A, Dung VC, et al. Therapies for the bone in mucopolysaccharidoses. Mol Genet Metab. 2015;114(2):94\u2013109. \n                    https:\/\/doi.org\/10.1016\/j.ymgme.2014.12.001\n                    \n                  .","journal-title":"Mol Genet Metab"},{"issue":"2","key":"9460_CR35","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ymgme.2013.11.015","volume":"111","author":"J Muenzer","year":"2014","unstructured":"Muenzer J. Early initiation of enzyme replacement therapy for the mucopolysaccharidoses. Mol Genet Metab. 2014;111(2):63\u201372. \n                    https:\/\/doi.org\/10.1016\/j.ymgme.2013.11.015\n                    \n                  .","journal-title":"Mol Genet Metab"},{"issue":"3","key":"9460_CR36","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s10545-011-9304-x","volume":"34","author":"MH Linden van der","year":"2011","unstructured":"van der Linden MH, Kruyt MC, Sakkers RJ, de Koning TJ, Oner FC, Castelein RM. Orthopaedic management of Hurler's disease after hematopoietic stem cell transplantation: a systematic review. J Inherit Metab Dis. 2011;34(3):657\u201369. \n                    https:\/\/doi.org\/10.1007\/s10545-011-9304-x\n                    \n                  .","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"9460_CR37","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s10545-016-9974-5","volume":"39","author":"JB Hennermann","year":"2016","unstructured":"Hennermann JB, Gokce S, Solyom A, Mengel E, Schuchman EH, Simonaro CM. Treatment with pentosan polysulphate in patients with MPS I: results from an open label, randomized, monocentric phase II study. J Inherit Metab Dis. 2016;39(6):831\u20137. \n                    https:\/\/doi.org\/10.1007\/s10545-016-9974-5\n                    \n                  .","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"9460_CR38","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1148\/119.2.401","volume":"119","author":"J Spranger","year":"1976","unstructured":"Spranger J, Gehler J, Cantz M. The radiographic features of mannosidosis. Radiology. 1976;119(2):401\u20137. \n                    https:\/\/doi.org\/10.1148\/119.2.401\n                    \n                  .","journal-title":"Radiology"},{"issue":"1","key":"9460_CR39","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1750-1172-8-88","volume":"8","author":"Michael Beck","year":"2013","unstructured":"Beck M, Olsen KJ, Wraith JE, Zeman J, Michalski JC, Saftig P, et al. Natural history of alpha mannosidosis a longitudinal study. Orphanet J Rare Dis. 2013;8:88. \n                    https:\/\/doi.org\/10.1186\/1750-1172-8-88\n                    \n                  .","journal-title":"Orphanet Journal of Rare Diseases"},{"issue":"1","key":"9460_CR40","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s10067-003-0770-x","volume":"23","author":"AH Gerards","year":"2004","unstructured":"Gerards AH, Winia WP, Westerga J, Dijkmans BA, van Soesbergen RM. Destructive joint disease in alpha-mannosidosis. A case report and review of the literature. Clin Rheumatol. 2004;23(1):40\u20132. \n                    https:\/\/doi.org\/10.1007\/s10067-003-0770-x\n                    \n                  .","journal-title":"Clin Rheumatol"},{"issue":"1","key":"9460_CR41","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10545-013-9622-2","volume":"37","author":"D Malm","year":"2014","unstructured":"Malm D, Riise Stensland HM, Edvardsen O, Nilssen O. The natural course and complications of alpha-mannosidosis--a retrospective and descriptive study. J Inherit Metab Dis. 2014;37(1):79\u201382. \n                    https:\/\/doi.org\/10.1007\/s10545-013-9622-2\n                    \n                  .","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"9460_CR42","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.jpeds.2004.01.025","volume":"144","author":"Satkiran S. Grewal","year":"2004","unstructured":"Grewal SS, Shapiro EG, Krivit W, Charnas L, Lockman LA, Delaney KA, et al. Effective treatment of alpha-mannosidosis by allogeneic hematopoietic stem cell transplantation. J Pediatr. 2004;144(5):569\u201373. \n                    https:\/\/doi.org\/10.1016\/j.jpeds.2004.01.025\n                    \n                  .","journal-title":"The Journal of Pediatrics"},{"issue":"7","key":"9460_CR43","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/j.1399-3046.2012.01763.x","volume":"16","author":"AM Yesilipek","year":"2012","unstructured":"Yesilipek AM, Akcan M, Karasu G, Uygun V, Kupesiz A, Hazar V. Successful unrelated bone marrow transplantation in two siblings with alpha-mannosidosis. Pediatr Transplant. 2012;16(7):779\u201382. \n                    https:\/\/doi.org\/10.1111\/j.1399-3046.2012.01763.x\n                    \n                  .","journal-title":"Pediatr Transplant"},{"key":"9460_CR44","doi-asserted-by":"crossref","unstructured":"Bedilu R, Nummy KA, Cooper A, Wevers R, Smeitink J, Kleijer WJ, et al. Variable clinical presentation of lysosomal beta-mannosidosis in patients with null mutations. Mol Genet Metab. 2002;77(4):282\u201390.","DOI":"10.1016\/S1096-7192(02)00172-5"},{"issue":"5279","key":"9460_CR45","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1126\/science.273.5279.1236","volume":"273","author":"BD Gelb","year":"1996","unstructured":"Gelb BD, Shi GP, Chapman HA, Desnick RJ. Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science. 1996;273(5279):1236\u20138.","journal-title":"Science"},{"issue":"124","key":"9460_CR46","first-page":"433","volume":"21","author":"M Lamy","year":"1965","unstructured":"Lamy M, Maroteaux P. Pycnodysostosis. Rev Esp Pediatr. 1965;21(124):433\u20137.","journal-title":"Rev Esp Pediatr"},{"issue":"1","key":"9460_CR47","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1750-1172-6-20","volume":"6","author":"Yang Xue","year":"2011","unstructured":"Xue Y, Cai T, Shi S, Wang W, Zhang Y, Mao T, et al. Clinical and animal research findings in pycnodysostosis and gene mutations of cathepsin K from 1996 to 2011. Orphanet J Rare Dis. 2011;6:20. \n                    https:\/\/doi.org\/10.1186\/1750-1172-6-20\n                    \n                  .","journal-title":"Orphanet Journal of Rare Diseases"},{"key":"9460_CR48","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1750-1172-9-60","volume":"9","author":"A Arman","year":"2014","unstructured":"Arman A, Bereket A, Coker A, Kiper PO, Guran T, Ozkan B, et al. Cathepsin K analysis in a pycnodysostosis cohort: demographic, genotypic and phenotypic features. Orphanet J Rare Dis. 2014;9:60. \n                    https:\/\/doi.org\/10.1186\/1750-1172-9-60\n                    \n                  .","journal-title":"Orphanet J Rare Dis"},{"key":"9460_CR49","doi-asserted-by":"publisher","first-page":"4352485","DOI":"10.1155\/2017\/4352485","volume":"2017","author":"H Aghili","year":"2017","unstructured":"Aghili H, Tabatabaei SMA, Goldani MM. Clinical and radiographic features of Pycnodysostosis with emphasis on Dentofacial problems. Case Rep Dent. 2017;2017:4352485. \n                    https:\/\/doi.org\/10.1155\/2017\/4352485\n                    \n                  .","journal-title":"Case Rep Dent"},{"issue":"8","key":"9460_CR50","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1002\/ajmg.a.36557","volume":"164","author":"Elisa Testani","year":"2014","unstructured":"Testani E, Scarano E, Leoni C, Dittoni S, Losurdo A, Colicchio S, et al. Upper airway surgery of obstructive sleep apnea in pycnodysostosis: case report and literature review. Am J Med Genet A. 2014;164A(8):2029\u201335. \n                    https:\/\/doi.org\/10.1002\/ajmg.a.36557\n                    \n                  .","journal-title":"American Journal of Medical Genetics Part A"},{"key":"9460_CR51","unstructured":"Introne WJ, Gahl WA. Alkaptonuria. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K et al., editors. GeneReviews((R)). Seattle (WA) 1993. Available from \n                    http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1454\/\n                    \n                   PubMed PMID: 20301627. Accessed 1 June 2018."},{"issue":"6","key":"9460_CR52","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/s10545-011-9374-9","volume":"34","author":"LR Ranganath","year":"2011","unstructured":"Ranganath LR, Cox TF. Natural history of alkaptonuria revisited: analyses based on scoring systems. J Inherit Metab Dis. 2011;34(6):1141\u201351. \n                    https:\/\/doi.org\/10.1007\/s10545-011-9374-9\n                    \n                  .","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"9460_CR53","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s10545-015-9844-6","volume":"38","author":"JB Arnoux","year":"2015","unstructured":"Arnoux JB, Le Quan Sang KH, Brassier A, Grisel C, Servais A, Wippf J, et al. Old treatments for new insights and strategies: proposed management in adults and children with alkaptonuria. J Inherit Metab Dis. 2015;38(5):791\u20136. \n                    https:\/\/doi.org\/10.1007\/s10545-015-9844-6\n                    \n                  .","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"9460_CR54","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1136\/annrheumdis-2014-206033","volume":"75","author":"Lakshminarayan R Ranganath","year":"2014","unstructured":"Ranganath LR, Milan AM, Hughes AT, Dutton JJ, Fitzgerald R, Briggs MC, et al. Suitability of Nitisinone in Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose-response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisic acid excretion in patients with alkaptonuria after 4 weeks of treatment. Ann Rheum Dis. 2016;75(2):362\u20137. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2014-206033\n                    \n                  .","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"3","key":"9460_CR55","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10545-017-0029-3","volume":"40","author":"AI Coelho","year":"2017","unstructured":"Coelho AI, Rubio-Gozalbo ME, Vicente JB, Rivera I. Sweet and sour: an update on classic galactosemia. J Inherit Metab Dis. 2017;40(3):325\u201342. \n                    https:\/\/doi.org\/10.1007\/s10545-017-0029-3\n                    \n                  .","journal-title":"J Inherit Metab Dis"},{"key":"9460_CR56","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/8904_2016_28","volume":"35","author":"B Erven van","year":"2017","unstructured":"van Erven B, Welling L, van Calcar SC, Doulgeraki A, Eyskens F, Gribben J, et al. Bone health in classic Galactosemia: systematic review and Meta-analysis. JIMD Rep. 2017;35:87\u201396. \n                    https:\/\/doi.org\/10.1007\/8904_2016_28\n                    \n                  .","journal-title":"JIMD Rep"},{"issue":"2","key":"9460_CR57","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s00198-012-1983-0","volume":"24","author":"L. A. Batey","year":"2012","unstructured":"Batey LA, Welt CK, Rohr F, Wessel A, Anastasoaie V, Feldman HA, et al. Skeletal health in adult patients with classic galactosemia. Osteoporos Int. 2013;24(2):501\u20139. \n                    https:\/\/doi.org\/10.1007\/s00198-012-1983-0\n                    \n                  .","journal-title":"Osteoporosis International"},{"issue":"2","key":"9460_CR58","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s10545-011-9372-y","volume":"35","author":"Susan E. Waisbren","year":"2011","unstructured":"Waisbren SE, Potter NL, Gordon CM, Green RC, Greenstein P, Gubbels CS, et al. The adult galactosemic phenotype. J Inherit Metab Dis. 2012;35(2):279\u201386. \n                    https:\/\/doi.org\/10.1007\/s10545-011-9372-y\n                    \n                  .","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"5","key":"9460_CR59","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.bone.2006.05.002","volume":"39","author":"B Panis","year":"2006","unstructured":"Panis B, Vermeer C, van Kroonenburgh M, Nieman FHM, Menheere P, Spaapen LJ, et al. Effect of calcium, vitamins K1 and D3 on bone in galactosemia. Bone. 2006;39(5):1123\u20139. \n                    https:\/\/doi.org\/10.1016\/j.bone.2006.05.002\n                    \n                  .","journal-title":"Bone"},{"issue":"2","key":"9460_CR60","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s10545-010-9221-4","volume":"34","author":"JL Fridovich-Keil","year":"2011","unstructured":"Fridovich-Keil JL, Gubbels CS, Spencer JB, Sanders RD, Land JA, Rubio-Gozalbo E. Ovarian function in girls and women with GALT-deficiency galactosemia. J Inherit Metab Dis. 2011;34(2):357\u201366. \n                    https:\/\/doi.org\/10.1007\/s10545-010-9221-4\n                    \n                  .","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"9460_CR61","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jbspin.2008.11.002","volume":"76","author":"R Levasseur","year":"2009","unstructured":"Levasseur R. Bone tissue and hyperhomocysteinemia. Joint Bone Spine. 2009;76(3):234\u201340. \n                    https:\/\/doi.org\/10.1016\/j.jbspin.2008.11.002\n                    \n                  .","journal-title":"Joint Bone Spine"},{"key":"9460_CR62","unstructured":"Mudd SH, Skovby F, Levy HL, Pettigrew KD, Wilcken B, Pyeritz RE, et al. The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet. 1985;37(1):1\u201331."},{"issue":"3","key":"9460_CR63","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ymgme.2015.12.003","volume":"117","author":"David R. Weber","year":"2016","unstructured":"Weber DR, Coughlin C, Brodsky JL, Lindstrom K, Ficicioglu C, Kaplan P, et al. Low bone mineral density is a common finding in patients with homocystinuria. Mol Genet Metab. 2016;117(3):351\u20134. \n                    https:\/\/doi.org\/10.1016\/j.ymgme.2015.12.003\n                    \n                  .","journal-title":"Molecular Genetics and Metabolism"},{"issue":"1","key":"9460_CR64","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s10545-016-9979-0","volume":"40","author":"AA Morris","year":"2017","unstructured":"Morris AA, Kozich V, Santra S, Andria G, Ben-Omran TI, Chakrapani AB, et al. Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency. J Inherit Metab Dis. 2017;40(1):49\u201374. \n                    https:\/\/doi.org\/10.1007\/s10545-016-9979-0\n                    \n                  .","journal-title":"J Inherit Metab Dis"},{"issue":"9","key":"9460_CR65","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1007\/s00198-013-2351-4","volume":"24","author":"JS Lim","year":"2013","unstructured":"Lim JS, Lee DH. Changes in bone mineral density and body composition of children with well-controlled homocystinuria caused by CBS deficiency. Osteoporos Int. 2013;24(9):2535\u20138. \n                    https:\/\/doi.org\/10.1007\/s00198-013-2351-4\n                    \n                  .","journal-title":"Osteoporos Int"},{"issue":"7","key":"9460_CR66","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1023\/A:1005445132327","volume":"21","author":"S Yap","year":"1998","unstructured":"Yap S, Naughten E. Homocystinuria due to cystathionine beta-synthase deficiency in Ireland: 25 years' experience of a newborn screened and treated population with reference to clinical outcome and biochemical control. J Inherit Metab Dis. 1998;21(7):738\u201347.","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"9460_CR67","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1007\/s10545-008-0830-0","volume":"31","author":"HR Mundy","year":"2008","unstructured":"Mundy HR, Williams JE, Lee PJ, Fewtrell MS. Reduction in bone mineral density in glycogenosis type III may be due to a mixed muscle and bone deficit. J Inherit Metab Dis. 2008;31(3):418\u201323. \n                    https:\/\/doi.org\/10.1007\/s10545-008-0830-0\n                    \n                  .","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"9460_CR68","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.bone.2010.06.021","volume":"47","author":"LE Berg van den","year":"2010","unstructured":"van den Berg LE, Zandbergen AA, van Capelle CI, de Vries JM, Hop WC, van den Hout JM, et al. Low bone mass in Pompe disease: muscular strength as a predictor of bone mineral density. Bone. 2010;47(3):643\u20139. \n                    https:\/\/doi.org\/10.1016\/j.bone.2010.06.021\n                    \n                  .","journal-title":"Bone"},{"issue":"2","key":"9460_CR69","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1210\/jc.2014-2763","volume":"100","author":"Francesco Bertoldo","year":"2015","unstructured":"Bertoldo F, Zappini F, Brigo M, Moggio M, Lucchini V, Angelini C, et al. Prevalence of asymptomatic vertebral fractures in late-onset Pompe disease. J Clin Endocrinol Metab. 2015;100(2):401\u20136. \n                    https:\/\/doi.org\/10.1210\/jc.2014-2763\n                    \n                  .","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"6","key":"9460_CR70","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/BF02029361","volume":"154","author":"PJ Lee","year":"1995","unstructured":"Lee PJ, Patel JS, Fewtrell M, Leonard JV, Bishop NJ. Bone mineralisation in type 1 glycogen storage disease. Eur J Pediatr. 1995;154(6):483\u20137.","journal-title":"Eur J Pediatr"},{"issue":"3","key":"9460_CR71","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1067\/mpd.2002.126456","volume":"141","author":"B Schwahn","year":"2002","unstructured":"Schwahn B, Rauch F, Wendel U, Schonau E. Low bone mass in glycogen storage disease type 1 is associated with reduced muscle force and poor metabolic control. J Pediatr. 2002;141(3):350\u20136. \n                    https:\/\/doi.org\/10.1067\/mpd.2002.126456\n                    \n                  .","journal-title":"J Pediatr"},{"issue":"4","key":"9460_CR72","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1023\/A:1025111220095","volume":"26","author":"JP Rake","year":"2003","unstructured":"Rake JP, Visser G, Huismans D, Huitema S, van der Veer E, Piers DA, et al. Bone mineral density in children, adolescents and adults with glycogen storage disease type Ia: a cross-sectional and longitudinal study. J Inherit Metab Dis. 2003;26(4):371\u201384.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"9460_CR73","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1249\/MSS.0000000000001414","volume":"50","author":"I Rodriguez-Gomez","year":"2018","unstructured":"Rodriguez-Gomez I, Santalla A, Diez-Bermejo J, Munguia-Izquierdo D, Alegre LM, Nogales-Gadea G, et al. A new condition in McArdle disease: poor bone health-benefits of an active lifestyle. Med Sci Sports Exerc. 2018;50(1):3\u201310. \n                    https:\/\/doi.org\/10.1249\/MSS.0000000000001414\n                    \n                  .","journal-title":"Med Sci Sports Exerc"},{"issue":"1","key":"9460_CR74","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000351022","volume":"81","author":"D Melis","year":"2014","unstructured":"Melis D, Pivonello R, Cozzolino M, Della Casa R, Balivo F, Del Puente A, et al. Impaired bone metabolism in glycogen storage disease type 1 is associated with poor metabolic control in type 1a and with granulocyte colony-stimulating factor therapy in type 1b. Horm Res Paediatr. 2014;81(1):55\u201362. \n                    https:\/\/doi.org\/10.1159\/000351022\n                    \n                  .","journal-title":"Horm Res Paediatr"},{"key":"9460_CR75","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/8904_2016_38","volume":"36","author":"EM Wong","year":"2017","unstructured":"Wong EM, Lehman A, Acott P, Gillis J, Metzger DL, Sirrs S. Hypogonadotropic hypogonadism in males with glycogen storage disease type 1. JIMD Rep. 2017;36:79\u201384. \n                    https:\/\/doi.org\/10.1007\/8904_2016_38\n                    \n                  .","journal-title":"JIMD Rep"},{"key":"9460_CR76","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/gim.2012.36","volume":"14","author":"LA Minarich","year":"2012","unstructured":"Minarich LA, Kirpich A, Fiske LM, Weinstein DA. Bone mineral density in glycogen storage disease type Ia and Ib. Genet Med. 2012;14:737\u201341. \n                    https:\/\/doi.org\/10.1038\/gim.2012.36\n                    \n                  .","journal-title":"Genet Med"},{"issue":"4","key":"9460_CR77","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3978\/j.issn.2224-4336.2015.10.07","volume":"4","author":"N Hafid Al","year":"2015","unstructured":"Al Hafid N, Christodoulou J. Phenylketonuria: a review of current and future treatments. Transl Pediatr. 2015;4(4):304\u201317. \n                    https:\/\/doi.org\/10.3978\/j.issn.2224-4336.2015.10.07\n                    \n                  .","journal-title":"Transl Pediatr"},{"key":"9460_CR78","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13023-015-0232-y","volume":"10","author":"S Demirdas","year":"2015","unstructured":"Demirdas S, Coakley KE, Bisschop PH, Hollak CE, Bosch AM, Singh RH. Bone health in phenylketonuria: a systematic review and meta-analysis. Orphanet J Rare Dis. 2015;10:17. \n                    https:\/\/doi.org\/10.1186\/s13023-015-0232-y\n                    \n                  .","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"9460_CR79","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s10545-014-9735-2","volume":"37","author":"KE Hansen","year":"2014","unstructured":"Hansen KE, Ney D. A systematic review of bone mineral density and fractures in phenylketonuria. J Inherit Metab Dis. 2014;37(6):875\u201380. \n                    https:\/\/doi.org\/10.1007\/s10545-014-9735-2\n                    \n                  .","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"9460_CR80","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1159\/000465529","volume":"70","author":"Serwet Demirdas","year":"2017","unstructured":"Demirdas S, van Spronsen FJ, Hollak CEM, van der Lee JH, Bisschop PH, Vaz FM, et al. Micronutrients, essential fatty acids and bone health in phenylketonuria. Ann Nutr Metab. 2017;70(2):111\u201321. \n                    https:\/\/doi.org\/10.1159\/000465529\n                    \n                  .","journal-title":"Annals of Nutrition and Metabolism"},{"issue":"2-3","key":"9460_CR81","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s10545-006-0351-7","volume":"29","author":"G. Touati","year":"2006","unstructured":"Touati G, Valayannopoulos V, Mention K, de Lonlay P, Jouvet P, Depondt E, et al. Methylmalonic and propionic acidurias: management without or with a few supplements of specific amino acid mixture. J Inherit Metab Dis. 2006;29(2\u20133):288\u201398. \n                    https:\/\/doi.org\/10.1007\/s10545-006-0351-7\n                    \n                  .","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"4","key":"9460_CR82","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s10545-009-1191-12","volume":"32","author":"E Martin-Hernandez","year":"2009","unstructured":"Martin-Hernandez E, Lee PJ, Micciche A, Grunewald S, Lachmann RH. Long-term needs of adult patients with organic acidaemias: outcome and prognostic factors. J Inherit Metab Dis. 2009;32(4):523\u201333. \n                    https:\/\/doi.org\/10.1007\/s10545-009-1191-12\n                    \n                  .","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"9460_CR83","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s10545-005-0036-7","volume":"28","author":"G Wilcox","year":"2005","unstructured":"Wilcox G, Strauss BJ, Francis DE, Upton H, Boneh A. Body composition in young adults with inborn errors of protein metabolism--a pilot study. J Inherit Metab Dis. 2005;28(5):613\u201326. \n                    https:\/\/doi.org\/10.1007\/s10545-005-0036-7\n                    \n                  .","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"9460_CR84","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0002-9343(75)90358-7","volume":"59","author":"O Simell","year":"1975","unstructured":"Simell O, Perheentupa J, Rapola J, Visakorpi JK, Eskelin LE. Lysinuric protein intolerance. Am J Med. 1975;59(2):229\u201340.","journal-title":"Am J Med"},{"key":"9460_CR85","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ymgmr.2014.03.004","volume":"1","author":"Jennifer E. Posey","year":"2014","unstructured":"Posey JE, Burrage LC, Miller MJ, Liu P, Hardison MT, Elsea SH, et al. Lysinuric protein intolerance presenting with multiple fractures. Mol Genet Metab Rep. 2014;1:176\u201383. \n                    https:\/\/doi.org\/10.1016\/j.ymgmr.2014.03.004\n                    \n                  .","journal-title":"Molecular Genetics and Metabolism Reports"},{"issue":"5","key":"9460_CR86","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1056\/NEJM198501313120506","volume":"312","author":"TO Carpenter","year":"1985","unstructured":"Carpenter TO, Levy HL, Holtrop ME, Shih VE, Anast CS. Lysinuric protein intolerance presenting as childhood osteoporosis. Clinical and skeletal response to citrulline therapy. N Engl J Med. 1985;312(5):290\u20134. \n                    https:\/\/doi.org\/10.1056\/NEJM198501313120506\n                    \n                  .","journal-title":"N Engl J Med"},{"issue":"2","key":"9460_CR87","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/BF00710296","volume":"16","author":"K Parto","year":"1993","unstructured":"Parto K, Penttinen R, Paronen I, Pelliniemi L, Simell O. Osteoporosis in lysinuric protein intolerance. J Inherit Metab Dis. 1993;16(2):441\u201350.","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"9460_CR88","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/jbmr.2703","volume":"31","author":"A Jennings","year":"2016","unstructured":"Jennings A, MacGregor A, Spector T, Cassidy A. Amino acid intakes are associated with bone mineral density and prevalence of low bone mass in women: evidence from discordant monozygotic twins. J Bone Miner Res. 2016;31(2):326\u201335. \n                    https:\/\/doi.org\/10.1002\/jbmr.2703\n                    \n                  .","journal-title":"J Bone Miner Res"},{"issue":"1","key":"9460_CR89","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/ajmg.c.30287","volume":"157C","author":"G Sebastio","year":"2011","unstructured":"Sebastio G, Sperandeo MP, Andria G. Lysinuric protein intolerance: reviewing concepts on a multisystem disease. Am J Med Genet C: Semin Med Genet. 2011;157C(1):54\u201362. \n                    https:\/\/doi.org\/10.1002\/ajmg.c.30287\n                    \n                  .","journal-title":"Am J Med Genet C: Semin Med Genet"},{"issue":"5","key":"9460_CR90","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s10545-006-0236-9","volume":"29","author":"L Gomez","year":"2006","unstructured":"Gomez L, Garcia-Cazorla A, Gutierrez A, Artuch R, Varea V, Martin J, et al. Treatment of severe osteoporosis with alendronate in a patient with lysinuric protein intolerance. J Inherit Metab Dis. 2006;29(5):687. \n                    https:\/\/doi.org\/10.1007\/s10545-006-0236-9\n                    \n                  .","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"9460_CR91","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1111\/bjd.15893","volume":"177","author":"M. Biewenga","year":"2017","unstructured":"Biewenga M, Matawlie RHS, Friesema ECH, Koole-Lesuis H, Langeveld M, Wilson JHP, et al. Osteoporosis in patients with erythropoietic protoporphyria. Br J Dermatol. 2017;177(6):1693\u20138. \n                    https:\/\/doi.org\/10.1111\/bjd.15893\n                    \n                  .","journal-title":"British Journal of Dermatology"},{"issue":"3","key":"9460_CR92","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s12020-013-9934-x","volume":"44","author":"G Allo","year":"2013","unstructured":"Allo G, del Carmen G-AM, Mendez M, De Salamanca RE, Martinez G, Hawkins F. Bone mineral density and vitamin D levels in erythropoietic protoporphyria. Endocrine. 2013;44(3):803\u20137. \n                    https:\/\/doi.org\/10.1007\/s12020-013-9934-x\n                    \n                  .","journal-title":"Endocrine"},{"issue":"5","key":"9460_CR93","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s10545-015-9815-y","volume":"38","author":"KH Weiss","year":"2015","unstructured":"Weiss KH, Van de Moortele M, Gotthardt DN, Pfeiffenberger J, Seessle J, Ullrich E, et al. Bone demineralisation in a large cohort of Wilson disease patients. J Inherit Metab Dis. 2015;38(5):949\u201356. \n                    https:\/\/doi.org\/10.1007\/s10545-015-9815-y\n                    \n                  .","journal-title":"J Inherit Metab Dis"},{"issue":"11","key":"9460_CR94","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1007\/s00198-014-2806-2","volume":"25","author":"AS Quemeneur","year":"2014","unstructured":"Quemeneur AS, Trocello JM, Ea HK, Ostertag A, Leyendecker A, Duclos-Vallee JC, et al. Bone status and fractures in 85 adults with Wilson's disease. Osteoporos Int. 2014;25(11):2573\u201380. \n                    https:\/\/doi.org\/10.1007\/s00198-014-2806-2\n                    \n                  .","journal-title":"Osteoporos Int"},{"issue":"2","key":"9460_CR95","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1136\/ard.36.2.99","volume":"36","author":"DN Golding","year":"1977","unstructured":"Golding DN, Walshe JM. Arthropathy of Wilson's disease. Study of clinical and radiological features in 32 patients. Ann Rheum Dis. 1977;36(2):99\u2013111.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"9460_CR96","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.berh.2011.10.021","volume":"25","author":"AS Quemeneur","year":"2011","unstructured":"Quemeneur AS, Trocello JM, Ea HK, Woimant F, Liote F. Miscellaneous non-inflammatory musculoskeletal conditions. Musculoskeletal conditions associated with Wilson's disease. Best Pract Res Clin Rheumatol. 2011;25(5):627\u201336. \n                    https:\/\/doi.org\/10.1016\/j.berh.2011.10.021\n                    \n                  .","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"3","key":"9460_CR97","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s10545-017-0128-1","volume":"41","author":"Clara D. M. van Karnebeek","year":"2018","unstructured":"van Karnebeek CDM, Wortmann SB, Tarailo-Graovac M, Langeveld M, Ferreira CR, van de Kamp JM, et al. The role of the clinician in the multi-omics era: are you ready? J Inherit Metab Dis. 2018;41(3):571\u201382. \n                    https:\/\/doi.org\/10.1007\/s10545-017-0128-1\n                    \n                  .","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"9","key":"9460_CR98","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1302\/0301-620X.99B9.BJJ-2017-0487","volume":"99-B","author":"N Williams","year":"2017","unstructured":"Williams N, Challoumas D, Ketteridge D, Cundy PJ, Eastwood DM. The mucopolysaccharidoses: advances in medical care lead to challenges in orthopaedic surgical care. Bone Joint J. 2017;99-B(9):1132\u20139. \n                    https:\/\/doi.org\/10.1302\/0301-620X.99B9.BJJ-2017-0487\n                    \n                  .","journal-title":"Bone Joint J"},{"issue":"1","key":"9460_CR99","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ymgme.2013.03.004","volume":"109","author":"J Ruijter de","year":"2013","unstructured":"de Ruijter J, Maas M, Janssen A, Wijburg FA. High prevalence of femoral head necrosis in Mucopolysaccharidosis type III (Sanfilippo disease): a national, observational, cross-sectional study. Mol Genet Metab. 2013;109(1):49\u201353. \n                    https:\/\/doi.org\/10.1016\/j.ymgme.2013.03.004\n                    \n                  .","journal-title":"Mol Genet Metab"},{"key":"9460_CR100","unstructured":"Cimaz R, Vijay S, Haase C, Coppa GV, Bruni S, Wraith E, et al. Attenuated type I mucopolysaccharidosis in the differential diagnosis of juvenile idiopathic arthritis: a series of 13 patients with Scheie syndrome. Clin Exp Rheumatol. 2006;24(2):196\u2013202."}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11154-018-9460-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-018-9460-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-018-9460-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T19:18:06Z","timestamp":1568229486000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11154-018-9460-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["9460"],"URL":"https:\/\/doi.org\/10.1007\/s11154-018-9460-5","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"12 September 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Mirjam Langeveld and Carla Hollak have no conflict of interests concerning any aspectof the submitted work. Outside of the submitted work, they are involved in pre-marketing studies with Genzyme, Protalix and Idorsia. Financial arrangements are made through AMC Research BV. No fees, travel support or grants are obtained from the Pharmaceutical Industry.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}